Tyra Biosciences annual net debt
2020
2021
2022
2023
2024
2025
Tyra Biosciences Net Debt Growth & History (TYRA)
Tyra Biosciences's net debt was −$71.6M for fiscal 2025.
View full Tyra Biosciences company overviewTyra Biosciences annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$71.6M | $14.2M | — |
| 2024 | 2024-12-31 | −$85.7M | −$34.2M | — |
| 2023 | 2023-12-31 | −$51.5M | $197.1M | — |
| 2022 | 2022-12-31 | −$248.6M | $52.4M | — |
| 2021 | 2021-12-31 | −$301.0M | −$285.9M | — |
| 2020 | 2020-12-31 | −$15.1M | — | — |
Tyra Biosciences quarterly net debt
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$68.3M | $24.2M | — |
| Q1 2026 | 2026-03-31 | −$79.3M | $15.3M | — |
| Q4 2025 | 2025-12-31 | −$71.6M | $14.2M | — |
| Q3 2025 | 2025-09-30 | −$56.0M | $41.5M | — |
| Q2 2025 | 2025-06-30 | −$92.5M | $624,000 | — |
| Q1 2025 | 2025-03-31 | −$94.6M | $153.3M | — |
| Q4 2024 | 2024-12-31 | −$85.7M | −$34.2M | — |
| Q3 2024 | 2024-09-30 | −$97.6M | $112.0M | — |
| Q2 2024 | 2024-06-30 | −$93.1M | $133.3M | — |
| Q1 2024 | 2024-03-31 | −$247.9M | −$8.8M | — |
| Q4 2023 | 2023-12-31 | −$51.5M | $197.1M | — |
| Q3 2023 | 2023-09-30 | −$209.5M | $51.0M | — |
| Q2 2023 | 2023-06-30 | −$226.3M | $46.1M | — |
| Q1 2023 | 2023-03-31 | −$239.1M | $50.7M | — |
| Q4 2022 | 2022-12-31 | −$248.6M | $52.4M | — |
| Q3 2022 | 2022-09-30 | −$260.6M | $51.1M | — |
| Q2 2022 | 2022-06-30 | −$272.4M | — | — |
| Q1 2022 | 2022-03-31 | −$289.8M | — | — |
| Q4 2021 | 2021-12-31 | −$301.0M | −$285.9M | — |
| Q3 2021 | 2021-09-30 | −$311.7M | — | — |
| Q4 2020 | 2020-12-31 | −$15.1M | — | — |
Tyra Biosciences net debt trends
Over the last five fiscal years, Tyra Biosciences's net debt decreased from −$15.1M to −$71.6M, a change of −$56.5M. The latest reported quarter, Q2 2026, shows −$68.3M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tyra Biosciences source filings ↗